Trials / Terminated
TerminatedNCT00139607
Parecoxib In Post Surgery (Hemicolectomy) Pain
A Multicenter, Open Label, Pilot Study To Evaluate Analgesic Activity And Safety Of Parecoxib 40 Mg IV In Patients Undergoing Hemicolectomy, In The Optimal Management Of Acute Post-Operative Pain Of Surgical Patients
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase III, multicenter, open label, pilot to evaluate the analgesic efficacy and safety of parecoxib 40 mg IV in the treatment of the pain following hemicolectomy in an optimal management of the surgical patient
Detailed description
The study was terminated prematurely due to recruitment issues on 31 January 2006. Safety concerns did not lead to the decision to terminate this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paracoxib |
Timeline
- Start date
- 2002-09-01
- Completion
- 2005-01-01
- First posted
- 2005-08-31
- Last updated
- 2009-08-14
Locations
3 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT00139607. Inclusion in this directory is not an endorsement.